Christina Christoffersen Selected Research

Apolipoproteins M

7/2022	Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes.
10/2021	Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system.
1/2020	Apolipoprotein M and Risk of Type 2 Diabetes.
1/2019	Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology.
1/2019	Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
1/2018	Apolipoprotein M in patients with chronic kidney disease.
10/2017	Effects of apolipoprotein M in uremic atherosclerosis.
7/2013	Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
5/2012	Apolipoprotein M--a new biomarker in sepsis.
3/2012	Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina Christoffersen Research Topics

Disease

17	Atherosclerosis 02/2019 - 01/2008
8	Inflammation (Inflammations) 10/2021 - 08/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 03/2009
3	Chronic Renal Insufficiency 01/2021 - 12/2017
3	Fibrosis (Cirrhosis) 01/2020 - 12/2016
3	Obesity 01/2019 - 08/2003
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 05/2020
2	Reperfusion Injury 01/2021 - 03/2016
2	Sepsis (Septicemia) 01/2019 - 05/2012
2	Uremia 12/2017 - 10/2017
2	Coronary Disease (Coronary Heart Disease) 07/2016 - 05/2010
2	Hypoxia (Hypoxemia) 01/2016 - 01/2012
1	Hyperlipidemias (Hyperlipidemia) 05/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Heart Diseases (Heart Disease) 05/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hepatomegaly 12/2019
1	Proteinuria 12/2019
1	Body Weight (Weight, Body) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2019
1	Fatty Liver 01/2019
1	Anorexia 01/2019
1	Narcolepsy 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Xanthomatosis (Xanthoma) 10/2017
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 10/2017
1	Vascular Remodeling 12/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016
1	Cholestasis 12/2016
1	Thrombosis (Thrombus) 12/2016
1	Infarction (Infarctions) 03/2016

Drug/Important Bio-Agent (IBA)

12	Apolipoproteins MIBA 07/2022 - 01/2008
11	LipidsIBA 05/2022 - 08/2003
9	CholesterolIBA 01/2021 - 01/2008
6	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2010
5	oxidized low density lipoproteinIBA 01/2022 - 05/2010
5	Apolipoproteins E (ApoE)IBA 10/2017 - 05/2010
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
4	LigandsIBA 01/2022 - 01/2012
4	ApolipoproteinsIBA 12/2017 - 05/2010
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2012
3	HDL LipoproteinsIBA 01/2020 - 01/2008
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 03/2016
2	CalciumIBA 01/2022 - 12/2020
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 02/2013
2	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 01/2020
2	Galectin 3 (LGALS3)IBA 01/2021 - 12/2019
2	Liraglutide FDA Link 12/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
2	CreatinineIBA 01/2018 - 08/2015
2	Apolipoproteins B (ApoB)IBA 12/2017 - 11/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 05/2010
2	LDL Receptors (LDL Receptor)IBA 01/2013 - 01/2008
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Histidine (L-Histidine)FDA Link 01/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	thiocyanateIBA 01/2021
1	CreatineIBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 05/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2020
1	pro-brain natriuretic peptide (1-76)IBA 05/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2019
1	Hematoxylin (Haematoxylon)IBA 12/2019
1	6-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA 12/2019
1	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 12/2019
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 12/2019
1	Vitamin D-Binding ProteinIBA 12/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2019
1	SphingosineIBA 01/2019
1	MelanocortinsIBA 01/2019
1	peptide PIBA 01/2019
1	NeurotensinIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018
1	fibroblast growth factor 21IBA 01/2018
1	OrexinsIBA 01/2018
1	SEW2871IBA 12/2016
1	HDL CholesterolIBA 07/2016
1	Connexin 43 (Connexin43)IBA 03/2016
1	Troponin IIBA 03/2016
1	ConnexinsIBA 03/2016
1	Alanine (L-Alanine)FDA Link 03/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	CarrageenanIBA 01/2016
1	low density lipoprotein inhibitorIBA 11/2015

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2019
1	Drug Tapering 01/2019
1	Nephrectomy 10/2017
1	Hepatectomy 12/2016